mometasone furoate


Also found in: Dictionary, Wikipedia.

mometasone furoate

(mō-mĕt′ə-sōn′)
n.
A synthetic corticosteroid used as a topical anti-inflammatory and antipruritic, as a nasal spray in the treatment of allergic rhinitis, and as an inhalant in the maintenance treatment of asthma.

mometasone furoate

Asmanex®, Nasonex®, Twisthaler® Therapeutics An inhaled steroid used for seasonal allergic rhinitis and asthma
Mentioned in ?
References in periodicals archive ?
5% hydrocortisone Cream, ointment Low potency 1% hydrocortisone Cream, ointment Moderate potency Beclomethasone dipropionate Cream Clobctasonc butyrate Cream Fluticasone propionate Cream, ointment Hydrocortisone 17-bulyrate Cream, lipocream, ointment, lotion, emulsifying lotion Methylprednisolone acetonate 1% Milk, scalp solution, cream, ointment, fatty ointment Mometasone furoate Cream, ointment, lotion Potent Betamethasone valerate Cream, ointment, solution, scalp solution Fluocinolone acetonide Cream, ointment, gel Diflucortolone valerate Cream, fatty ointment, forte Very potent ointment Clobetasol propionate Cream, ointment, shampoo, scalp solution Belhamelasone dipropionate Cream, ointment Table 3.
applications: for a fixed-dose combination of mometasone furoate and
The collaboration was expanded in August 2006 to include the joint development and commercialization of a fixed-dose combination of indacaterol and mometasone furoate.
Mometasone furoate (Asmanex Twisthaler) is available as a DPI with 220 micrograms/actuation dosing.
once-daily mometasone furoate nasal spray significantly decreased total ocular symptom score compared with placebo (-1.
Mometasone furoate and fluticasone propionate are highly lipophilic, allowing greater uptake and retention into the nasal mucosa.
PROPEL mometasone furoate implant and PROPEL mini mometasone furoate implant .
ORLANDO - A combination of fixed-dose mometasone furoate and formoterol fumarate improved lung function in patients with moderate to very severe chronic obstructive pulmonary disease.
Six aqueous INS formulations are currently licensed for the treatment of adult and pediatric PAR in the US: beclomethasone dipropionate (BDP), budesonide, flunisolide, fluticasone propionate (FP), mometasone furoate (MF) and triamcinolone acetonide (TAA).
Like the company's PROPEL[TM] and PROPEL[TM] mini implants used in the operating room setting to improve surgical outcomes, the product being studied releases mometasone furoate, an advanced steroid with anti-inflammatory properties, directly into the sinus lining to resolve inflammation.
Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo.
Currently, only two medium- and low-potency topical therapies are approved for short-term use in pediatric psoriasis: mometasone furoate and alclometasone dipropionate.